StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1815 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to achieve more accurate early classification of diabetes and identification of which patients will rapidly require insulin treatment. The investigators will recruit 1200 participants who have been diagnosed with diabetes in the last year and were aged between 18 and 50 years at the time of diagnosis. The investigators will recruit an additional cohort of 800 participants diagnosed after age 50. The investigators will record clinical features and biomarkers that may help us to determine diabetes type at diagnosis and follow participants for 3 years to assess the development of severe insulin deficiency (measured using C-peptide) and insulin requirement. The investigators will assess utility of clinical features and additional biomarkers in identifying patients with rapid progression to insulin requirement. Findings will be integrated into a freely available clinical prediction models to assist classification of diabetes at diagnosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Screening and Understanding of the Pre-diabetes: DECODIAB

NCT01739868

Pre-diabetes

UNKNOWN NA

A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes

NCT00318032

Type 2 Diabetes Mellitus

UNKNOWN NA

AI Ready and Exploratory Atlas for Diabetes Insights

NCT06002048

Type 2 Diabetes

ENROLLING_BY_INVITATION

Subjects With T2D or at Risk of T2D Cohort Follow-up

NCT05567692

Diabetes Mellitus, Type 2

ACTIVE_NOT_RECRUITING

Evaluation of SCOUT DS in Subjects With Type 2 Diabetes

NCT01346033

Type 2 Diabetes

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a prospective observational study which will assess the relationship between clinical features and biomarkers at diabetes diagnosis and type of diabetes defined by endogenous insulin secretion at 3 years diabetes duration.

The investigators will recruit a prospective cohort of 1200 adults that have been diagnosed with diabetes within the previous 1 year and aged between 18 and 50 at the time of diagnosis. The investigators will also recruit an additional cohort of 800 participants diagnosed with diabetes in the last year aged \>50 at diabetes diagnosis, who will be stratified by insulin treatment (insulin treated n=400).

On recruitment into the study, non-fasting (within 1-5 hours of a meal) blood sample will be collected for baseline analysis biomarker assessment (serum C-peptide, routine biochemistry, Islet autoantibodies (GAD, IA2, ZnT8)) and biobanking. Clinical features will be recorded, including weight, height, waist/hip ratio \& blood pressure. Participants will be asked to provide a home post-meal urine sample for Urinary C-Peptide Creatinine Ratio (UCPCR). At 1 year and 2 years post recruitment, participants will be contacted by telephone, email or in person to record concurrent treatment, hypoglycaemia and health service utilisation. Participants will be asked to collect a home post-meal urine sample for Urinary C-Peptide /Creatinine Ratio (UCPCR). HbA1c results will be obtained from participants GP practice or laboratory records.

At the end of the study, 3 years post recruitment, a non-fasting blood sample will be collected for serum C-peptide, routine biochemistry and stored for future biomarker analysis. Weight change, blood pressure, concurrent treatment, hypoglycaemia and health service utilisation data will be also be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 Age 18-50 at diagnosis

Diagnosed with diabetes within the previous 1 year. Aged between 18 and 50 years at the time of diabetes diagnosis

No interventions assigned to this group

Group 2 Late Onset (insulin)

Diagnosed with diabetes within the previous 1 year. Aged \>50 at the time of diabetes diagnosis and treated with insulin therapy

No interventions assigned to this group

Group 3 Late Onset (no insulin)

Diagnosed with diabetes within the previous 1 year. Aged \>50 at the time of diabetes diagnosis and treated without insulin

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults diagnosed with diabetes within the previous 12 months.
* Aged ≥18 and ≤50 at the time of diabetes diagnosis\* or (additional late onset diabetes cohort) aged \>50 at the time of diabetes diagnosis.
* Able and willing to provide informed consent

Exclusion Criteria

* Gestational diabetes.
* Known secondary diabetes (diabetes considered likely due to medication, cystic fibrosis, pancreatitis, pancreatic cancer, pancreatic surgery, hemochromatosis or Cushing's syndrome).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No